Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials
NCT01546012 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2015-09-02
Summary
Assess the patient feeling about the handiness of two different vials used to deliver both, unpreserved hyaluronic eye drops.
Conditions
- Assess the Patient Feeling About the Handiness of Two Different Vials Used to Deliver Both, Unpreserved Hyaluronic Eye Drops
Interventions
- DEVICE
-
HYABAK®
Hyaluronic Acid eye drops CE marked, packaged in multidose ABAK® container (preservative free)
- DEVICE
-
HYLO-COMOD®
Hyaluronic Acid eye drops CE marked, packaged in multidose COMOD® container (preservative free)
Sponsors & Collaborators
-
Axial Biotech, Inc
collaborator INDUSTRY -
Laboratoires Thea
lead INDUSTRY
Principal Investigators
-
Carl Erb · Augenklinik, Wittenbergplatz, Kleiststrasse 23-26, 10787 Berlin
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Germany
Study Locations
More Related Trials
-
Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms
NCT00761202 ·Status: COMPLETED ·Phase: PHASE4
-
Piiloset Trehalose Emulsion Eye Drop Study in Moderate or Severe Dry Eye
NCT03569202 ·Status: COMPLETED ·Phase: NA
-
Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease
NCT03048526 ·Status: COMPLETED ·Phase: NA
-
Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye
NCT06860659 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation
NCT04633863 ·Status: COMPLETED ·Phase: NA
-
Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
NCT07245836 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye Syndrome
NCT03161080 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
Tolerability, Safety and Efficacy of Lubricin Versus Sodium Hyaluronate Eye Drops in Patients With Moderate Dry Eye
NCT02507934 ·Status: COMPLETED ·Phase: NA
-
Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome
NCT02585453 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP® MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye
NCT06686368 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Evaluation of Performance and Safety of Eye Drops With Hyaluronic Acid 0.30% and 0.15%
NCT06189456 ·Status: RECRUITING ·Phase: NA
-
PMCF Study to Evaluate Performance and Safety of "CLHA-based Eyedrops" Used to Improve Lacrimal Abnormalities
NCT05823961 ·Status: COMPLETED ·Phase: NA
-
Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye Syndrome
NCT02585648 ·Status: COMPLETED ·Phase: NA
-
Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease
NCT01753596 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
NCT01135511 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of a Moisturizing Product on Dry Eye and Skin
NCT02683382 ·Status: COMPLETED ·Phase: NA
-
Local Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers
NCT01278784 ·Status: COMPLETED ·Phase: PHASE1
-
I-DROP MGD Symptomatic Relief and Tear Film Stability
NCT05011708 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
NCT03162094 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Switching From Xiidra to TRYPTYR
NCT07267481 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
NCT06544694 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Laquinimod Eye-drops in Healthy Participants
NCT05187403 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating Drops
NCT02758327 ·Status: COMPLETED ·Phase: PHASE4